UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Validation of a Nurse Led Triage Algorithm for New Referrals in a Specialized Pulmonary Hypertension Clinic

The Journal of heart and lung transplantation, 2020-04, Vol.39 (4), p.S493-S493

2020

Volltextzugriff (PDF)

Beta-interferon exposure and onset of secondary progressive multiple sclerosis

European journal of neurology, 2015-06, Vol.22 (6), p.990-1000

2015

Volltextzugriff (PDF)

MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability

Neurology, 2006-05, Vol.66 (9), p.1384-1389

2006

Volltextzugriff (PDF)

Interferon β-1b-neutralizing antibodies 5 years after clinically isolated syndrome

Neurology, 2011-08, Vol.77 (9), p.835-843

2011

Volltextzugriff (PDF)

MRI-based clinical trials in relapsing–remitting MS: new sample size calculations based on a longitudinal model

Multiple sclerosis, 2012-11, Vol.18 (11), p.1600-1608

2012

Volltextzugriff (PDF)

Does MRI lesion activity regress in secondary progressive multiple sclerosis?

Multiple sclerosis, 2010-04, Vol.16 (4), p.434-442

2010

Volltextzugriff (PDF)

Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study

European journal of neurology, 2014-06, Vol.21 (6), p.835-844

2014

Volltextzugriff (PDF)

Neutralizing antibodies during treatment of secondary progressive MS with interferon β-1b

Neurology, 2003-01, Vol.60 (1), p.37-43

2003

Volltextzugriff (PDF)

A Novel Method for Assessing the Effect of Case-Mix and Model Calibration on the Receiver Operating Characteristic (ROC) Plot, With a Case Study in Chronic Obstructive Pulmonary Disease

Annals of epidemiology, 2020-12, Vol.52, p.114-114

2020

Volltextzugriff (PDF)

Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment

Neurology, 2008-03, Vol.70 (13 Pt 2), p.1134-1140

2008

Volltextzugriff (PDF)

Magnetic resonance imaging as a surrogate outcome for multiple sclerosis relapses

Multiple sclerosis, 2008-07, Vol.14 (6), p.770-778

2008

Volltextzugriff (PDF)

Exposure of Chronic Obstructive Pulmonary Disease Patients to Particulate Matter: Relationships between Personal and Ambient Air Concentrations

Journal of the Air & Waste Management Association, 2000-07, Vol.50 (7), p.1081-1094

2000

Volltextzugriff (PDF)

Predicting gadolinium enhancement status in MS patients eligible for randomized clinical trials

Neurology, 2005-11, Vol.65 (9), p.1447-1454

2005

Volltextzugriff (PDF)

20-YEAR TRENDS IN ASTHMA HOSPITAL ADMISSIONS IN CANADA

Chest, 2022-06, Vol.161 (6), p.A365-A365

2022

Volltextzugriff (PDF)

Informing Medication Discontinuation Decisions among Older Adults with Relapsing-Onset Multiple Sclerosis

Drugs & aging, 2020-03, Vol.37 (3), p.225-235

2020

Volltextzugriff (PDF)

Sequence database versioning for command line and Galaxy bioinformatics servers

Bioinformatics, 2016-04, Vol.32 (8), p.1275-1277

2016

Volltextzugriff (PDF)

Molecular markers and antioxidant activity in berry crops: Genetic diversity analysis

Canadian journal of plant science, 2012-11, Vol.92 (6), p.1121-1133

2012

Volltextzugriff (PDF)

Marginal Structural Cox Models for Estimating the Association Between β-Interferon Exposure and Disease Progression in a Multiple Sclerosis Cohort

American journal of epidemiology, 2014-07, Vol.180 (2), p.160-171

2014

Volltextzugriff (PDF)

Liver test abnormalities in multiple sclerosis: findings from placebo-treated patients

Neurology, 2006-10, Vol.67 (7), p.1291-1293

2006

Volltextzugriff (PDF)

Evaluating the safety of β-interferons in MS: A series of nested case-control studies

Neurology, 2017-06, Vol.88 (24), p.2310-2320

2017

Volltextzugriff (PDF)

Evaluation of safety monitoring guidelines based on MRI lesion activity in multiple sclerosis

Neurology, 2011-12, Vol.77 (24), p.2089-2096

2011

Volltextzugriff (PDF)

Exposure Misclassification and Threshold Concentrations in Time Series Analyses of Air Pollution Health Effects

Risk analysis, 2002-12, Vol.22 (6), p.1183-1193

2002

Volltextzugriff (PDF)

Multiple Sclerosis in Older Adults: The Clinical Profile and Impact of Interferon Beta Treatment

BioMed research international, 2015-01, Vol.2015 (2015), p.1-11

2015

Volltextzugriff (PDF)

Accurate classification of secondary progression in multiple sclerosis using a decision tree

Multiple sclerosis, 2021-07, Vol.27 (8), p.1240-1249

2021

Volltextzugriff (PDF)

Estimating inverse probability weights using super learner when weight‐model specification is unknown in a marginal structural Cox model context

Statistics in medicine, 2017-06, Vol.36 (13), p.2032-2047

2017

Volltextzugriff (PDF)

1 – 25 von 146

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(138)
Mit Volltextzugriff
(116)

Publikationsform

Artikel
(144)
Tagungsberichte
(2)

Sprache

Englisch
(145)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Validation of a Nurse Led Triage Algorithm for New Referrals in a Specialized Pulmonary Hypertension Clinic

Beta-interferon exposure and onset of secondary progressive multiple sclerosis

MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability

Interferon β-1b-neutralizing antibodies 5 years after clinically isolated syndrome

MRI-based clinical trials in relapsing–remitting MS: new sample size calculations based on a longitudinal model

Does MRI lesion activity regress in secondary progressive multiple sclerosis?

Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study

Neutralizing antibodies during treatment of secondary progressive MS with interferon β-1b

A Novel Method for Assessing the Effect of Case-Mix and Model Calibration on the Receiver Operating Characteristic (ROC) Plot, With a Case Study in Chronic Obstructive Pulmonary Disease

Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment

Magnetic resonance imaging as a surrogate outcome for multiple sclerosis relapses

Exposure of Chronic Obstructive Pulmonary Disease Patients to Particulate Matter: Relationships between Personal and Ambient Air Concentrations

Predicting gadolinium enhancement status in MS patients eligible for randomized clinical trials

20-YEAR TRENDS IN ASTHMA HOSPITAL ADMISSIONS IN CANADA

Informing Medication Discontinuation Decisions among Older Adults with Relapsing-Onset Multiple Sclerosis

Sequence database versioning for command line and Galaxy bioinformatics servers

Molecular markers and antioxidant activity in berry crops: Genetic diversity analysis

Marginal Structural Cox Models for Estimating the Association Between β-Interferon Exposure and Disease Progression in a Multiple Sclerosis Cohort

Liver test abnormalities in multiple sclerosis: findings from placebo-treated patients

Evaluating the safety of β-interferons in MS: A series of nested case-control studies

Evaluation of safety monitoring guidelines based on MRI lesion activity in multiple sclerosis

Exposure Misclassification and Threshold Concentrations in Time Series Analyses of Air Pollution Health Effects

Multiple Sclerosis in Older Adults: The Clinical Profile and Impact of Interferon Beta Treatment

Accurate classification of secondary progression in multiple sclerosis using a decision tree

Estimating inverse probability weights using super learner when weight‐model specification is unknown in a marginal structural Cox model context

Suchergebnisse filtern